Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill

Objectives: To evaluate acceptability, safety, and continuation rates of centchroman following abortion.Study design: Prospective, observational study. Following spontaneous/induced abortion, women were of-fered centchroman, 30-mg tablet twice weekly for first 3 months, then once weekly with 1 year of follow-up.Results: Of 120 women who opted for centchroman, continuation rate was 91% at 12 months. There was one case of user failure and one method failure and 26% had infrequent cycles.Conclusions: Centchroman is safe, effective, has good acceptance, and continuation rate post abortion with infrequent menstrual cycles as the main limiting factor for its continuation.Implications: Centchroman, available in Government scheme for contraception, has good acceptance and continuation rate post abortion. Its inclusion in contraceptive choices offered for postabortion contra-ception can go a long way in spacing of pregnancies, decreasing repeated unintended pregnancies, unsafe abortions, maternal morbidity, and mortality.(c) 2023 Elsevier Inc. All rights reserved.